Cargando…
Misuse of "study drugs:" prevalence, consequences, and implications for policy
BACKGROUND: Non-medical/illegal use of prescription stimulants popularly have been referred to as "study drugs". This paper discusses the current prevalence and consequences of misuse of these drugs and implications of this information for drug policy. RESULTS: Study drugs are being misuse...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1524735/ https://www.ncbi.nlm.nih.gov/pubmed/16764722 http://dx.doi.org/10.1186/1747-597X-1-15 |
_version_ | 1782128833412988928 |
---|---|
author | Sussman, Steve Pentz, Mary Ann Spruijt-Metz, Donna Miller, Toby |
author_facet | Sussman, Steve Pentz, Mary Ann Spruijt-Metz, Donna Miller, Toby |
author_sort | Sussman, Steve |
collection | PubMed |
description | BACKGROUND: Non-medical/illegal use of prescription stimulants popularly have been referred to as "study drugs". This paper discusses the current prevalence and consequences of misuse of these drugs and implications of this information for drug policy. RESULTS: Study drugs are being misused annually by approximately 4% of older teens and emerging adults. Yet, there are numerous consequences of misuse of prescription stimulants including addiction, negative reactions to high dosages, and medical complications. Policy implications include continuing to limit access to study drugs, finding more safe prescription drug alternatives, interdiction, and public education. CONCLUSION: Much more work is needed on prescription stimulant misuse assessment, identifying the extent of the social and economic costs of misuse, monitoring and reducing access, and developing prevention and cessation education efforts. |
format | Text |
id | pubmed-1524735 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-15247352006-07-29 Misuse of "study drugs:" prevalence, consequences, and implications for policy Sussman, Steve Pentz, Mary Ann Spruijt-Metz, Donna Miller, Toby Subst Abuse Treat Prev Policy Review BACKGROUND: Non-medical/illegal use of prescription stimulants popularly have been referred to as "study drugs". This paper discusses the current prevalence and consequences of misuse of these drugs and implications of this information for drug policy. RESULTS: Study drugs are being misused annually by approximately 4% of older teens and emerging adults. Yet, there are numerous consequences of misuse of prescription stimulants including addiction, negative reactions to high dosages, and medical complications. Policy implications include continuing to limit access to study drugs, finding more safe prescription drug alternatives, interdiction, and public education. CONCLUSION: Much more work is needed on prescription stimulant misuse assessment, identifying the extent of the social and economic costs of misuse, monitoring and reducing access, and developing prevention and cessation education efforts. BioMed Central 2006-06-09 /pmc/articles/PMC1524735/ /pubmed/16764722 http://dx.doi.org/10.1186/1747-597X-1-15 Text en Copyright © 2006 Sussman et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Sussman, Steve Pentz, Mary Ann Spruijt-Metz, Donna Miller, Toby Misuse of "study drugs:" prevalence, consequences, and implications for policy |
title | Misuse of "study drugs:" prevalence, consequences, and implications for policy |
title_full | Misuse of "study drugs:" prevalence, consequences, and implications for policy |
title_fullStr | Misuse of "study drugs:" prevalence, consequences, and implications for policy |
title_full_unstemmed | Misuse of "study drugs:" prevalence, consequences, and implications for policy |
title_short | Misuse of "study drugs:" prevalence, consequences, and implications for policy |
title_sort | misuse of "study drugs:" prevalence, consequences, and implications for policy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1524735/ https://www.ncbi.nlm.nih.gov/pubmed/16764722 http://dx.doi.org/10.1186/1747-597X-1-15 |
work_keys_str_mv | AT sussmansteve misuseofstudydrugsprevalenceconsequencesandimplicationsforpolicy AT pentzmaryann misuseofstudydrugsprevalenceconsequencesandimplicationsforpolicy AT spruijtmetzdonna misuseofstudydrugsprevalenceconsequencesandimplicationsforpolicy AT millertoby misuseofstudydrugsprevalenceconsequencesandimplicationsforpolicy |